We recommend that you upgrade to the latest version of your browser.
Illustrasjon av en forsker som underviser
A comprehensive investment in the cancer treatment of the future.

Ahus Cancer Centre

The Ahus Cancer Centre is the hospital's central unit for diagnostics, treatment, research, and development in the field of cancer. Our aim is to ensure patients receive a comprehensive, coordinated, and evidence-based treatment offer of high quality – now and in the future.

 

Through gradual development and strengthening of cancer treatment services, coherent patient pathways and comprehensive cancer care shall be created.
Ahus Development Plan 2040

 

Illustrasjon av en pasient som ligger i en sykehusseng med pårørende og lege ved siden av
Ahus Cancer Centre will provide treatment-related research with direct significance for the patient.

Annual reports

Our annual reports summarize the Cancer Center's activities, achievements, and strategic development. They showcase advances in cancer research, clinical practice, education, innovation, and collaboration, and provide insight into our efforts to improve outcomes for patients with cancer.

Organisation

Cancer Board – strategic management

Ahus Cancer Centre is led by the Cancer Board, which has the overall responsibility for direction, coordination, and priorities in the development of the cancer centre. The Cancer Board consists of directors from divisions responsible for cancer-related areas and is chaired by Erik Borge Skei, Director of the Medical Division at Ahus.

  1. Navn

    Erik Borge Skei

    Head of the Cancer Center Board

  2. Navn

    Anne Karin Lindal

    Director of Surgery

  3. Navn

    Janne Pedersen

    Director of Diagnostics and Techonology

  4. Navn

    Pernille Schjønsby

    Director of Gynecology

  5. Navn

    Kirsten Haugland

    Director of Pediatrics

  6. Navn

    Christine Lager Nesje

    Norwegian Cancer Society

  7. Navn

    Helge Røsjø

    Director of Research and Innovations

  8. Navn

    Geir Arne Larsen

    Head of Cancer Care Development

Cancer Council – advisory body

The Cancer Council is the professional advisory body of the cancer centre and consists of department heads from cancer-related fields. The Council provides input to the Cancer Board and contributes to ensuring professional anchoring and collaboration in the development work.

  1. Navn

    Anita Berg Petersen

    Dep Head Oncology

  2. Navn

    Anne Edvardsen

    Dep Head of Pulmonology

  3. Navn

    Elin Augustdottir

    Dep Head of Breast and Endocrine Surgery

  4. Navn

    Ellen Brodin

    Dep Head of Hemathology

  5. Navn

    Frode Olsbø

    Dep Head of Vascular and Thoracic Surgery

  6. Navn

    Frode Eidset

    Dep Head of Gastrointestinal Medicine

  7. Navn

    Geir Bøhler

    Dep Head of Gastrointestinal Surgery

  8. Navn

    Hilde Stømner

    Dep Head of Physiotherapy and Nutrition

  9. Navn

    Ida Årving

    Dep Head of Gynecology

  10. Navn

    Ivar Vølstad

    Dep Head of Otolaryngology

  11. Navn

    Nina Krogh

    Dep Head of Radiology

  12. Navn

    Olav Fredheim

    Dep Head of Palliative Care

  13. Navn

    Stig Müller

    Dep Head of Urology

  14. Navn

    Ulla Haave

    Dep Head of Pathology

Divisions and departments that are part of the cancer centre

  1. A man with a beard

    Navn

    Geir Arne Larsen

    Program leader cancer treatment and diagnostics

    geir.arne.larsen@ahus.no
  2. A person wearing a white shirt

    Navn

    Jostein Dahle

    Special advisor

    jostein.dahle@ahus.no
  3. A man smiling for the camera

    Navn

    Øyvind Antonsen

    Assistant Director of Subject Area

    oyvind.antonsen@ahus.no
  4. Portrettbilde av Trude Andreassen

    Navn

    Trude Andreassen

    Project Manager

    trude.andreassen@ahus.no

Quality Assurance

We work systematically and purposefully to ensure high quality in all aspects of cancer treatment. The cancer centre adheres to national professional standards, participates in external audits, and actively uses inspection reports in our improvement work.

The Cancer Centre and our support functions are regularly subject to audits by regional bodies and supervisory authorities. These reports are important tools in our quality work and demonstrate how we strive for safe and predictable patient care.

Accreditations:

Audit and supervisory reports:

  • Supervision at the blood bank (2025)
    • Conducted by the Norwegian Medicines Agency
    • The supervision assessed blood collection, testing, processing, storage, and release of blood and blood components, as well as the implementation of the blood bank's quality system.
    • The supervision found generally satisfactory operations but identified several minor deviations and one major deviation related to the haemoglobin limit during platelet apheresis, as well as a need for improvements in documentation, training, and storage of reagents.

  • Supervision at the blood bank (2023)
    • Conducted by the Norwegian Medicines Agency
    • The supervision covered the blood bank's operations at several locations and assessed blood collection, virus screening, component production, and quality systems.
    • The supervision showed that the blood bank is well managed and in compliance with regulations, but identified some minor deviations related to training and assessment of blood donors' suitability.

  • Supervision of the handling of blood, blood components, cells, and tissues (Health Supervision, 2023)
    • Conducted by Health Supervision
    • The supervision assessed the entire chain for handling blood, blood components, human cells, and tissues at Ahus.
    • No deviations were found, and Health Supervision concluded that Ahus has good and satisfactory routines in all assessed areas.

  • Medicinal preparedness in Health South-East (2023)
    • Conducted by the Group Audit in Health South-East (regional level)
    • The audit assessed regional management of medicinal preparedness, including distribution of responsibilities, emergency plans, storage strategies, and collaboration with Hospital Pharmacies HF.
    • The audit revealed significant variations between health enterprises, unclear responsibilities at the regional level, and a need for clearer management, follow-up, and coordination of emergency work.

  • Outsourcing of patients (2023)
    • Conducted by the Group Audit in Health South-East
    • The audit assessed whether Ahus has sufficient routines, lines of responsibility, training, and collaboration processes to ensure safe treatment of outsourced patients during overcapacity.
    • The audit found a substantial extent of outsourcing and identified risks related to unclear responsibilities, inadequate collaboration, missing transfer lists, and insufficient training in receiving units.

  • Transfer of patients between health enterprises (Ahus–OUS) (2022)
    • Conducted by the Group Audit in Health South-East
    • The audit assessed information flow, documentation, and collaboration during the transfer of patients between hospitals.
    • The audit revealed risks related to inadequate or incomplete information, manual and poorly standardised processes, and weaknesses in digital collaboration that could lead to delays and mismanagement.

  • Unwanted variation in healthcare services (2021)
    • Conducted by the Group Audit in Health South-East
    • The audit assessed how health enterprises use quality data and management information to reduce unwanted variation in treatment, quality, and practice.
    • The audit identified significant variation between enterprises and professional areas and called for more systematic use of quality registers, stronger management foundations, and better anchoring of improvement work.

Useful Links

Last updated 7/10/2026